ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | -12.0% | 5,837 | -32.9% | 0.00% | -20.0% |
| Q2 2022 | $75,000 | -32.4% | 8,700 | +383.3% | 0.01% | +25.0% |
| Q4 2021 | $111,000 | +5.7% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $105,000 | -24.5% | 1,800 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $139,000 | +23.0% | 1,800 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $113,000 | -75.1% | 1,800 | -80.0% | 0.01% | -76.2% |
| Q4 2020 | $454,000 | +150.8% | 9,000 | +25.0% | 0.02% | +90.9% |
| Q3 2020 | $181,000 | +26.6% | 7,200 | +16.1% | 0.01% | +10.0% |
| Q2 2020 | $143,000 | +62.5% | 6,200 | +6.9% | 0.01% | +150.0% |
| Q1 2020 | $88,000 | -33.8% | 5,800 | -68.0% | 0.00% | -50.0% |
| Q4 2019 | $133,000 | +125.4% | 18,108 | +94.7% | 0.01% | +60.0% |
| Q3 2019 | $59,000 | +742.9% | 9,300 | +386.9% | 0.01% | – |
| Q4 2017 | $7,000 | +16.7% | 1,910 | -5.0% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 2,010 | -4.7% | 0.00% | – |
| Q2 2017 | $6,000 | -94.8% | 2,110 | -96.6% | 0.00% | -100.0% |
| Q1 2017 | $116,000 | +28.9% | 62,038 | -0.5% | 0.01% | +66.7% |
| Q4 2016 | $90,000 | -86.3% | 62,338 | -42.7% | 0.00% | -89.7% |
| Q3 2016 | $655,000 | +39.1% | 108,728 | +20.6% | 0.03% | +20.8% |
| Q2 2016 | $471,000 | – | 90,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |